Mostafa Hammam: Antibody Panels in Blood Bank Feeling Like a Chaotic Puzzle? Here is How to Master the Grid
Mostafa Hammam, Blood Bank Laboratory Technician at Specialized Medical Centers in Egypt, shared a post on LinkedIn:
“Antibody panels in Blood Bank feeling like a chaotic puzzle? Here is how to master the grid.
Solving antibody panels is one of the most critical skills in Blood Banking and a top topic on the ASCP exam.
It might look intimidating at first, but it all comes down to pattern recognition.
Here are the 4 fundamental steps to decode any antibody panel with confidence:
1. Rule Out on Negative Cells only
The Rule: You can only rule out an antibody if a cell expresses the antigen but produces a negative reaction.
Why? If the reaction is positive, you don’t know which specific antibody is causing it, so positive cells cannot be used for rule-outs.
2. Check the Phase of Reactivity
Immediate Spin (IS) / Room Temp: Usually indicates clinically insignificant cold-reacting IgM antibodies (e.g., Anti-M, Anti-N, Anti-P1, Anti-Lea/Leb).
37°C / AHG (Coombs) Phase: Indicates clinically significant IgG antibodies that can cause HTR or HDFN (e.g., Rh, Kell, Kidd, Duffy).
3. Evaluate Reaction Strengths
Single Strength (e.g., all 2+): Usually points to a single antibody.
Variable Strengths (e.g., 1+, 3+, 2+): Suggests dosage (homozygous vs. heterozygous expression) or multiple antibodies reacting together (especially in Kidd, Duffy, and MNS systems).
4. Confirm with Patient Antigen Typing (Phenotyping)
The Rule: A patient can only make an antibody against an antigen they lacks.
If the patient types negative for the antigen, they are capable of forming the corresponding antibody.
Antibody identification is basically detective work!
Compare reactivity phases, antigen profiles, and reaction consistency until the pattern fits.
Once the pattern fits, the antibody makes perfect sense!”

Stay updated with Hemostasis Today.
-
Nov 13, 2026, 03:21Abdul Muqtadir Abbasi: Iron Deficiency Beyond Anemia and the Importance of Finding the Cause
-
Nov 13, 2026, 03:05Marc Carrier: Aspirin vs Anticoagulants for VTE Prevention After Joint Replacement
-
Nov 13, 2026, 02:28Julia Sjöberg: ROCK1 Inhibition and Red Blood Cell Recovery After Chemotherapy
-
Nov 13, 2026, 02:07Tonie Reincke: Understanding Deep Vein Thrombosis and Vascular Health
-
Nov 13, 2026, 01:52Akshita Singh: The Remarkable Process of Blood Clotting
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience